Inovio Pharmaceuticals, Inc.
Oral mucosal electroporation device and use thereof

Last updated:

Abstract:

The present invention relates to electroporation (EP) devices that are able to generate an electroporation causing electrical field at the mucosal layer, and preferably in a tolerable manner. Further, it includes the generation of a protective immune response, cellular and/or humoral, using the oral EP device along with a genetic construct that encodes an immunogenic sequence.

Status:
Grant
Type:

Utility

Filling date:

12 Nov 2018

Issue date:

2 Feb 2021